-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Moderna Says Received FDA Approval For RSV Vaccine, Mresvia, In Adults Aged 18–59 At Increased Risk For RSV Disease

Reuters·06/13/2025 00:02:12

Please log in to view news